CONMED Management

Management criteria checks 3/4

CONMED's CEO is Curt Hartman, appointed in Jul 2014, has a tenure of 9.83 years. total yearly compensation is $7.76M, comprised of 12.2% salary and 87.8% bonuses, including company stock and options. directly owns 0.29% of the company’s shares, worth $5.97M. The average tenure of the management team and the board of directors is 9 years and 8.8 years respectively.

Key information

Curt Hartman

Chief executive officer

US$7.8m

Total compensation

CEO salary percentage12.2%
CEO tenure9.8yrs
CEO ownership0.3%
Management average tenure9yrs
Board average tenure8.8yrs

Recent management updates

Recent updates

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Apr 18
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Is CONMED (NYSE:CNMD) Using Too Much Debt?

Mar 28
Is CONMED (NYSE:CNMD) Using Too Much Debt?

CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

Feb 15
CONMED Corporation (NYSE:CNMD) Might Not Be As Mispriced As It Looks After Plunging 26%

US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Feb 03
US$111: That's What Analysts Think CONMED Corporation (NYSE:CNMD) Is Worth After Its Latest Results

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Jan 08
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$107?

Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

Dec 18
Investors Appear Satisfied With CONMED Corporation's (NYSE:CNMD) Prospects

CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Nov 30
CONMED (NYSE:CNMD) Takes On Some Risk With Its Use Of Debt

Conmed: Sector Derating And A New Competitive Threat Shouldn't Overshadow A Solid Core Business

Oct 28

Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Sep 22
Is CONMED Corporation (NYSE:CNMD) Potentially Undervalued?

Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Aug 24
Does CONMED (NYSE:CNMD) Have A Healthy Balance Sheet?

Conmed: Reiterate Buy Rating As Earnings Are Expected To Grow Strongly

Jul 28

Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

Jun 08
Should You Think About Buying CONMED Corporation (NYSE:CNMD) Now?

These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

May 17
These 4 Measures Indicate That CONMED (NYSE:CNMD) Is Using Debt Extensively

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Apr 28
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Mar 10
Why CONMED Corporation (NYSE:CNMD) Could Be Worth Watching

Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

Feb 14
Here's Why CONMED (NYSE:CNMD) Has A Meaningful Debt Burden

CONMED Non-GAAP EPS of $0.42 misses by $0.48, revenue of $250.9M misses by $51.58M

Feb 02

Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

Jan 24
Estimating The Intrinsic Value Of CONMED Corporation (NYSE:CNMD)

ConMed: Still Fairly Priced, Turning More Constructive

Dec 09

At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Nov 18
At US$83.60, Is CONMED Corporation (NYSE:CNMD) Worth Looking At Closely?

Conmed withdraws FY22 guidance on software implementation-related disruption

Nov 15

CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

Oct 11
CONMED (NYSE:CNMD) Has A Pretty Healthy Balance Sheet

ConMed: Fairly Priced At Pre-Pandemic Market Cap

Sep 21

CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

Sep 03
CONMED (NYSE:CNMD) Has Announced A Dividend Of $0.20

CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

Aug 18
CONMED (NYSE:CNMD) Has Affirmed Its Dividend Of $0.20

CONMED declares $0.20 dividend

Aug 11

Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

Jul 20
Should You Investigate CONMED Corporation (NYSE:CNMD) At US$98.47?

We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Jun 23
We Think CONMED (NYSE:CNMD) Can Stay On Top Of Its Debt

Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Jun 10
Here's Why I Think CONMED (NYSE:CNMD) Might Deserve Your Attention Today

Estimating The Fair Value Of CONMED Corporation (NYSE:CNMD)

May 25
Estimating The Fair Value Of CONMED Corporation (NYSE:CNMD)

CEO Compensation Analysis

How has Curt Hartman's remuneration changed compared to CONMED's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

US$82m

Dec 31 2023US$8mUS$950k

US$64m

Sep 30 2023n/an/a

US$58m

Jun 30 2023n/an/a

US$88m

Mar 31 2023n/an/a

-US$94m

Dec 31 2022US$8mUS$946k

-US$81m

Sep 30 2022n/an/a

-US$83m

Jun 30 2022n/an/a

-US$114m

Mar 31 2022n/an/a

US$68m

Dec 31 2021US$9mUS$918k

US$63m

Sep 30 2021n/an/a

US$62m

Jun 30 2021n/an/a

US$54m

Mar 31 2021n/an/a

US$13m

Dec 31 2020US$6mUS$888k

US$10m

Sep 30 2020n/an/a

US$311k

Jun 30 2020n/an/a

US$431k

Mar 31 2020n/an/a

US$34m

Dec 31 2019US$6mUS$842k

US$29m

Sep 30 2019n/an/a

US$29m

Jun 30 2019n/an/a

US$28m

Mar 31 2019n/an/a

US$31m

Dec 31 2018US$5mUS$791k

US$41m

Sep 30 2018n/an/a

US$72m

Jun 30 2018n/an/a

US$73m

Mar 31 2018n/an/a

US$71m

Dec 31 2017US$3mUS$753k

US$55m

Compensation vs Market: Curt's total compensation ($USD7.76M) is above average for companies of similar size in the US market ($USD5.72M).

Compensation vs Earnings: Curt's compensation has been consistent with company performance over the past year.


CEO

Curt Hartman (59 yo)

9.8yrs

Tenure

US$7,764,615

Compensation

Mr. Curt R. Hartman has been Chairman of the Board at CONMED Corporation since May 21, 2020. Mr. Hartman has been the Chief Executive Officer and President of CONMED Corporation since November 09, 2014. Mr...


Leadership Team

NamePositionTenureCompensationOwnership
Curt Hartman
Chairman of the Board9.8yrsUS$7.76m0.29%
$ 6.0m
Todd Garner
Executive VP of Finance & CFO6.3yrsUS$2.87m0.00074%
$ 15.5k
Patrick Beyer
Chief Operating Officerless than a yearUS$3.30m0.025%
$ 530.8k
Heather Cohen
Executive VP11.2yrsUS$1.83m0.14%
$ 2.9m
Stanley Peters
President of Advanced Surgical & Advanced Endoscopic Technologies9.3yrsUS$2.00m0.0048%
$ 101.1k
Peter Shagory
Executive Vice President of Strategy & Corporate Development9yrsno data0.012%
$ 252.3k
Shanna Cotti-Osmanski
Executive VP of Information Technology & CIO4.2yrsno datano data
John Ferrell
Executive Vice President of Human Resources1.4yrsno data0.0023%
$ 47.7k
Daniel Jonas
Special Counsel & Corporate Secretary6yrsUS$1.55m0.044%
$ 915.2k
David Murray
President of ConMed Electrosurgery19.8yrsUS$572.33kno data
Terence Berge
VP & Corporate Controller9.1yrsno data0.0033%
$ 68.3k
Johonna Pelletier
VP of Tax & Treasurer9.1yrsno data0.0043%
$ 89.6k

9.0yrs

Average Tenure

54yo

Average Age

Experienced Management: CNMD's management team is seasoned and experienced (9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Curt Hartman
Chairman of the Board10.2yrsUS$7.76m0.29%
$ 6.0m
John Workman
Independent Director8.8yrsUS$257.37k0.065%
$ 1.4m
David Bronson
Independent Director8.8yrsUS$264.87k0.049%
$ 1.0m
Brian Concannon
Independent Director10.8yrsUS$257.37k0.030%
$ 634.6k
LaVerne Council
Independent Director4.4yrsUS$257.37k0.011%
$ 222.2k
Martha Aronson
Lead Independent Director8.3yrsUS$292.37k0.038%
$ 789.2k
Jerome Lande
Independent Director10.2yrsUS$257.37k0.012%
$ 241.6k
Charles Farkas
Independent Director9.8yrsUS$249.87k0.064%
$ 1.3m
Barbara Schwarzentraub
Independent Director4.7yrsUS$264.87k0.012%
$ 242.3k

8.8yrs

Average Tenure

61yo

Average Age

Experienced Board: CNMD's board of directors are considered experienced (8.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.